Per Malmström

Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs (2008)

Brommesson, Sara, Jönsson, Göran, Strand, Carina, Grabau, Dorthe, Malmström, Per, Ringnér, Markus, ...

Abstract Background Today, no objective criteria exist to differentiate between individual primary tumors and intra- or intermammary dissemination respectively, in patients diagnosed with two or more...

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy (2008)

Niméus-Malmström, Emma, Krogh, Morten, Malmström, Per, Strand, Carina, Fredriksson, Irma, Karlsson, Per, ...

Abstract Introduction Some patients with breast cancer develop local recurrence after breast-conservation surgery despite postoperative radiotherapy, whereas others remain free of local recurrence...

Exploring the two-gene ratio in breast cancer – independent roles for HOXB13 and IL17BR in prediction of clinical outcome (2008)

Jerevall, Piiha-Lotta, Brommesson, Sara, Strand, Carina, Gruvberger-Saal, Sofia, Malmström, Per, Nordenskjöld, Bo, ...

Background: The two-gene expression ratio HOXB13:IL17BR has been proposed to predict the outcome of tamoxifen-treated breast cancer patients. We intended to examine whether this ratio can predict the...

Psychological profile in patients with Stages I and II breast cancer: associations of psychological profile with tumor biological prognosticators. (2003)

Lilja, Asa, Smith, Gudmund, Malmström, Per, Salford, Leif G, Idvall, Ingrid, Horstman, Vibeke

We have earlier shown that breast cancer patients with moderately or well differentiated tumors seem to be able to inhibit stress evoked from anger in a successful manner, while those with poorer...

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

Saal, Lao H., Johansson, Peter, Holm, Karolina, Gruvberger-Saal, Sofia K., She, Qing-Bai, Maurer, Matthew, ...

Pathway-specific therapy is the future of cancer management. The oncogenic phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in solid tumors; however, currently, no reliable test...